{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:03:05Z","timestamp":1781596985805,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vph.2024.107435","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T19:03:41Z","timestamp":1729019021000},"page":"107435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study"],"prefix":"10.1016","volume":"157","author":[{"given":"Ali","family":"Khattib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Shmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achinoam","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majdi","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soliman","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2024.107435_bb0065","doi-asserted-by":"crossref","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob. Heart"},{"key":"10.1016\/j.vph.2024.107435_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/life12060842","article-title":"Novel DERMA fusion technique for ECG heartbeat classification","volume":"12","author":"Mastoi","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.vph.2024.107435_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081938","article-title":"Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease","volume":"10","author":"Fr\u0105k","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.vph.2024.107435_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2016282","article-title":"Automated diagnosis of coronary artery disease: a review and workflow","volume":"2018","author":"Mastoi","year":"2018","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.vph.2024.107435_bb0035","first-page":"221","article-title":"The role of coronary arterial spasm in ischemic heart disase","volume":"105","author":"Buja","year":"1981","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.vph.2024.107435_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-84628-715-2_76","article-title":"Atherosclerosis: pathologic anatomy and pathogenesis","volume":"1581\u20131591","author":"Buja","year":"2007","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.vph.2024.107435_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/11.suppl_E.41","article-title":"Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit","volume":"11","author":"Buja","year":"1990","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2024.107435_bb0210","article-title":"Coronary artery disease: pathologic anatomy and PathogenesMaximilian Buja, L., &McAllister, H. A. (2007). Coronary artery disease: pathologic anatomy and pathogenesis. Cardiovascular medicine, mi, 593\u2013610. Doi:10.1007\/978-1-84628-715-2_25is","volume":"593\u2013610","author":"Maximilian Buja","year":"2007","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.vph.2024.107435_bb0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2024.107435_bb0230","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1152\/physrev.00005.2003","article-title":"Role of monocytes in atherogenesis","volume":"83","author":"\u00d8sterud","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2024.107435_bb0020","doi-asserted-by":"crossref","first-page":"10E","DOI":"10.1016\/j.amjcard.2009.09.014","article-title":"Lessons learned from the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial","volume":"104","author":"Barter","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2024.107435_bb0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.vph.2024.107435_bb0085","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of Loss-of-Function Mutations in the ABCA1 gene with high-density","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2024.107435_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbacli.2015.01.005","article-title":"High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk","volume":"3","author":"Hafiane","year":"2015","journal-title":"BBA Clin."},{"key":"10.1016\/j.vph.2024.107435_bb0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2024.107435_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2013.11.001","article-title":"Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease","volume":"146","author":"Dumas","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vph.2024.107435_bb0295","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2024.107435_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-76146-7","article-title":"HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: the cardiovascular risk in young Finns study","volume":"10","author":"Hunjadi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2024.107435_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13060695","article-title":"Coronary artery disease with elevated levels of HDL cholesterol is associated with distinct lipid signatures","volume":"13","author":"Xia","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.vph.2024.107435_bb0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-012-0235-2","article-title":"High-density lipoprotein and atherosclerosis: the role of antioxidant activity","volume":"14","author":"Bandeali","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.vph.2024.107435_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10760296211029710","article-title":"Scavenger receptor BI induced by HDL from coronary heart disease may be related to atherosclerosis","volume":"27","author":"Gao","year":"2021","journal-title":"Clin. Appl. Thromb."},{"key":"10.1016\/j.vph.2024.107435_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm12061010","article-title":"Role of ABCA1 in cardiovascular disease","volume":"12","author":"Wang","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.vph.2024.107435_bb0320","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","article-title":"Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2024.107435_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25245980","article-title":"The structure and function of Paraoxonase-1 and its comparison to Paraoxonase-2 and-3","volume":"25","author":"Taler-Ver\u010di\u010d","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.vph.2024.107435_bb0185","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly prospective study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2024.107435_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(98)00064-7","article-title":"Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification","volume":"423","author":"MacKness","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vph.2024.107435_bb0270","first-page":"1284","article-title":"The role of \u201cparaoxonase-1 activity\u201d as an antioxidant in coronary artery diseases","volume":"7","author":"Shekhanawar","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.vph.2024.107435_bb0010","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","article-title":"Cardiovascular disease risk reduction by raising HDL cholesterol \u2013 current therapies and future opportunities","volume":"167","author":"Ali","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2024.107435_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2015.08.027","article-title":"HDL: quality or quantity?","volume":"243","author":"Santos-Gallego","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2024.107435_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11102058","article-title":"Lyso-DGTS Lipid Derivatives Enhance PON1 Activities and Prevent Oxidation of LDL: A Structure\u2013Activity Relationship Study","volume":"11","author":"Khattib","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.vph.2024.107435_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/biof.1580","article-title":"Lyso-diacylglyceryltrimethylhomoserine (lyso-DGTS) isolated from Nannochloropsis microalgae improves high-density lipoprotein (HDL) functions","volume":"46","author":"Khattib","year":"2020","journal-title":"BioFactors"},{"key":"10.1016\/j.vph.2024.107435_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/biof.1427","article-title":"Lyso-DGTS lipid isolated from microalgae enhances PON1 activities in vitro and in vivo, increases PON1 penetration into macrophages and decreases cellular lipid accumulation","author":"Dahli","year":"2018","journal-title":"BioFactors"},{"key":"10.1016\/j.vph.2024.107435_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2023.105367","article-title":"Novel bioactive lipids enhanced HDL-mediated cholesterol efflux from macrophages through the ABCA1 receptor pathway","volume":"258","author":"Khattib","year":"2024","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.vph.2024.107435_bb0140","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s10811-017-1373-2","article-title":"Nannochloropsis sp. ethanol extract prevents macrophage and LDL oxidation and enhances PON1 activity through the principal active compound lyso-diacylglyceryltrimethylhomoserine (lyso-DGTS)","volume":"30","author":"Khatib","year":"2018","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.vph.2024.107435_bb0115","first-page":"659","article-title":"HDL-mediated cellular cholesterol efflux assay method","volume":"45","author":"Hafiane","year":"2015","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.vph.2024.107435_bb0260","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1194\/jlr.D018051","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol","volume":"52","author":"Sankaranarayanan","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.vph.2024.107435_bb0220","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0022-2275(20)31582-0","article-title":"A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids","volume":"42","author":"Navab","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.vph.2024.107435_bb0175","first-page":"1","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.vph.2024.107435_bb0180","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2024.107435_bb0005","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.vph.2024.107435_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9080683","article-title":"Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes","volume":"9","author":"Rosta","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.vph.2024.107435_bb0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/1871529X18666180420170108","article-title":"Untargeted metabolomics in the discovery of novel biomarkers and therapeutic targets for atherosclerotic cardiovascular diseases","volume":"18","author":"Dang","year":"2018","journal-title":"Cardiovasc. Hematol. Disord. Targets"},{"key":"10.1016\/j.vph.2024.107435_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11883-010-0112-9","article-title":"Metabolomics and atherosclerosis","volume":"12","author":"Goonewardena","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.vph.2024.107435_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11110747","article-title":"Lipidomic profiling identifies signatures of poor cardiovascular health","volume":"11","author":"Rivas Serna","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.vph.2024.107435_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00025-1","article-title":"Lysophosphatidylethanolamine acyltransferase activity is elevated during cardiac cell differentiation. Biochim","volume":"1485","author":"Fotheringham","year":"2000","journal-title":"Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.vph.2024.107435_bb0275","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based bruneck study","volume":"129","author":"Stegemann","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2024.107435_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030579","article-title":"Lysophosphatidylethanolamine affects lipid accumulation and metabolism in a human liver-derived cell line","volume":"14","author":"Yamamoto","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.vph.2024.107435_bb0095","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1194\/jlr.M500054-JLR200","article-title":"Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine","volume":"46","author":"Gauster","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.vph.2024.107435_bb0330","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","article-title":"Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium","volume":"13","author":"Zhou","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.vph.2024.107435_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10557-008-6134-7","article-title":"Biology of secretory phospholipase A2","volume":"23","author":"Boyanovsky","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.vph.2024.107435_bb0325","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejvs.2018.07.004","article-title":"Identification of Lysophosphatidylcholines and sphingolipids as potential biomarkers for acute aortic dissection via serum metabolomics","volume":"57","author":"Zhou","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.vph.2024.107435_bb0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00011-012-0434-x","article-title":"Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine","volume":"61","author":"Hung","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.vph.2024.107435_bb0135","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.atherosclerosis.2007.02.012","article-title":"Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment","volume":"196","author":"Iwase","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2024.107435_bb0170","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1074\/jbc.RA118.002752","article-title":"Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation","volume":"293","author":"Li","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2024.107435_bb0305","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1074\/jbc.273.12.6830","article-title":"Lysophosphtidylcholine stimulates the release of arachidonic acid in human endothelial cells","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2024.107435_bb0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2249.1999.00871.x","article-title":"Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism","volume":"116","author":"Huang","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vph.2024.107435_bb0215","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.yjmcc.2003.08.004","article-title":"Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines","volume":"35","author":"Murugesan","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2024.107435_bb0285","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0026-0495(96)90024-4","article-title":"Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells","volume":"45","author":"Takahara","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.vph.2024.107435_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/14767050802556075","article-title":"Lysophosphatidylcholine induces endothelial cell injury by nitric oxide production through oxidative stress","volume":"22","author":"Kim","year":"2009","journal-title":"J. Matern. Neonatal Med."},{"key":"10.1016\/j.vph.2024.107435_bb0165","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1039\/C5FO00438A","article-title":"Sulforaphane protected the injury of human vascular endothelial cell induced by LPC through up-regulating endogenous antioxidants and phase II enzymes","volume":"6","author":"Li","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.vph.2024.107435_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.ATV.0000052673.77316.01","article-title":"Lysophosphatidylcholine inhibits endothelial cell migration by increasing intracellular calcium and activating calpain","volume":"23","author":"Chaudhuri","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2024.107435_bb0245","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.ATV.20.4.1006","article-title":"Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway","volume":"20","author":"Rikitake","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2024.107435_bb0235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.numecd.2017.07.011","article-title":"Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis","volume":"28","author":"Paapstel","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.vph.2024.107435_bb0280","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yped.2011.06.028","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"2012","author":"Stockman","year":"2012","journal-title":"Yearb. Pediatr."},{"key":"10.1016\/j.vph.2024.107435_bb0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jphs.2022.07.004","article-title":"HDL, cholesterol efflux, and ABCA1: free from good and evil dualism","volume":"150","author":"Ogura","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.vph.2024.107435_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T20:24:52Z","timestamp":1737836692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124001617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":66,"alternative-id":["S1537189124001617"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107435","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107435"}}